driving school
About:
Get recommendations from your friends, family and neighbours. More the people more the options
Description:
Biovica develops and commercializes blood-based biomarker assays that improve monitoring of modern cancer therapies and predict patient outcome. The company’s DiviTum™ assay, a test for accurately measuring cell proliferation, has successfully demonstrated its capabilities to early evaluate therapy effectiveness in several clinical trials. Biovica aims to make best-possible-treatment from day one a reality. Biovica collaborates with world-leading cancer institutes as well as pharmaceutical companies launching next-generation therapies. The company is ISO 13485 certified for Quality Management Systems. DiviTum™ is CE-labeled and MPA-registered.
19M SEK
$1M to $10M
Uppsala, Uppsala Lan, Sweden
2009-01-01
11-50
2024-10-03
Private
© 2025 bioDAO.ai